KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Regeneron Pharmaceuticals (REGN) Tax Rate (2016 - 2025)

Regeneron Pharmaceuticals has reported Tax Rate over the past 15 years, most recently at 19.08% for Q4 2025.

  • Quarterly results put Tax Rate at 19.08% for Q4 2025, up 1486.0% from a year ago — trailing twelve months through Dec 2025 was 13.88% (up 619.0% YoY), and the annual figure for FY2025 was 13.88%, up 619.0%.
  • Tax Rate for Q4 2025 was 19.08% at Regeneron Pharmaceuticals, up from 17.2% in the prior quarter.
  • Over the last five years, Tax Rate for REGN hit a ceiling of 19.08% in Q4 2025 and a floor of 3.04% in Q1 2024.
  • Median Tax Rate over the past 5 years was 10.39% (2023), compared with a mean of 9.7%.
  • Biggest five-year swings in Tax Rate: surged 1507bps in 2021 and later crashed -1068bps in 2023.
  • Regeneron Pharmaceuticals' Tax Rate stood at 10.96% in 2021, then decreased by -12bps to 9.63% in 2022, then crashed by -111bps to 1.05% in 2023, then surged by 503bps to 4.22% in 2024, then skyrocketed by 352bps to 19.08% in 2025.
  • The last three reported values for Tax Rate were 19.08% (Q4 2025), 17.2% (Q3 2025), and 8.37% (Q2 2025) per Business Quant data.